Science
Mechanism of Action
This extract operates by engaging with the skin's endogenous endocannabinoid system (ECS), specifically targeting CB1 and CB2 receptors located on keratinocytes and fibroblasts. Through this pathway, it modulates inflammatory cytokine production (such as TNF-α and IL-17), regulates lipid synthesis in sebocytes for a sebostatic effect, and preserves the dermal matrix by inhibiting degradative enzymes like collagenase and elastase.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 Significant increase in keratinocyte viability and cell integrity observed at concentrations as low as 0.01% (NIH, 2021).
- 02 Dermatitis models treated with a 2% high-CBD ointment demonstrated anti-inflammatory potency superior to 1% hydrocortisone (MDPI, 2024).
- 03 Standardized 5% extracts showed a significant downregulation of 26 inflammatory genes in human skin cells (NIH, 2020).
Transparency
Dusting Analysis
Due to the high cost of quality standardized extracts, brands often include it at 'label claim' levels (under 0.05%) which may provide antioxidant benefits but fail to trigger the significant anti-inflammatory gene modulation seen in clinical trials at 1-2% concentrations.
The Formula
Formulation
Stability
Highly susceptible to degradation from UV exposure, heat, and oxygen; requires opaque, airtight packaging and stabilization against oxidation.
Synergies
- Terpenes
- Ceramides
- Bisabolol
- Tocopherol
Conflicts
- Strong oxidizing agents
- Strong acids
- Highly alkaline environments (pH > 11)
- Direct sunlight
Safety
Safety Profile
SCCS 2025 guidelines suggest a 0.19% threshold for pure CBD in dermal applications. Standardized extracts must maintain THC levels below 0.3% to comply with FDA and EU regulations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance botanical that bridges the gap between traditional emollients and advanced neuro-cosmetic signaling.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources